Ignite Creation Date:
2024-05-05 @ 9:01 PM
Last Modification Date:
2024-10-26 @ 9:58 AM
Study NCT ID:
NCT00795418
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2008-11-10
Brief Title:
Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimers Patients
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 52-weekMulti-centerRandomizedDouble-blindPlacebo-controlledParallel Group Study in Patients With Mild Alzheimers Disease to Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and tolerability of repeated subcutaneous injections of CAD106 in patients with mid Alzheimers disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None